ECarboX protocol

Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer

-

Therapeutics: 5195

-

Drug Therapy: 116609

-

Combination Drug Therapy: 8322

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

ECarboX protocol

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

ECarboX protocol

-

Clinical Protocols

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

ECarboX protocol

-

Heterocyclic Compounds: 23

-

1-Ring Heterocyclic Compounds

-

Pyrimidines: 269

-

Pyrimidine Nucleosides: 38

-

Cytidine: 276

-

Deoxycytidine: 791

*

ECarboX protocol

-

Nucleic Acids, Nucleotides, and Nucleosides: 1

-

Nucleosides: 591

-

Pyrimidine Nucleosides: 38

-

Cytidine: 276

-

Deoxycytidine: 791

*

ECarboX protocol

-

Deoxyribonucleosides: 28

-

Deoxycytidine: 791

*

ECarboX protocol

-

Organic Chemicals: 40

-

Hydrocarbons: 382

-

Cyclic Hydrocarbons: 2

-

Aromatic Hydrocarbons: 115

-

Aromatic Polycyclic Hydrocarbons: 581

-

Naphthacenes

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15007

-

Epirubicin: 2010

*

ECarboX protocol

-

Organometallic Compounds: 5

-

Organoplatinum Compounds

-

Carboplatin: 4437

*

ECarboX protocol

-

Polycyclic Compounds: 58

-

Aromatic Polycyclic Hydrocarbons: 581

-

Naphthacenes

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15007

-

Epirubicin: 2010

*

ECarboX protocol

-

Carbohydrates: 2946

-

Glycosides: 339

-

Aminoglycosides: 1075

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15007

-

Epirubicin: 2010

*

ECarboX protocol

ECarboX protocol

Bio-Agent Context: Research Results